Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19

Coronavirus disease 2019 (COVID-19) is a pandemic with no specific drugs and high fatality. The most urgent need is to find effective treatments. We sought to determine whether hydroxychloroquine (HCQ) application may reduce the death risk of critically ill COVID-19 patients. In this retrospective s...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Bo, Li, Chenze, Chen, Peng, Zhou, Ning, Wang, Luyun, Li, Jia, Jiang, Hualiang, Wang, Dao-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Science China Press 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228868/
https://www.ncbi.nlm.nih.gov/pubmed/32418114
http://dx.doi.org/10.1007/s11427-020-1732-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228868/
https://www.ncbi.nlm.nih.gov/pubmed/32418114
http://dx.doi.org/10.1007/s11427-020-1732-2

Ejemplares similares